CN Stock MarketDetailed Quotes

300878 Zhejiang Wecome Pharmaceutical

Watchlist
  • 17.53
  • -1.24-6.61%
Post Market Dec 23 15:00 CST
2.54BMarket Cap-76.22P/E (TTM)

Zhejiang Wecome Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Chinese and western proprietary medicine222.56M74.94%
Traditional Chinese medicine slice43.93M14.79%
Total special adjustments28.04M9.44%
Other business2.46M0.83%
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
Drug sales294.74M99.24%
Other income1.56M0.53%
Total special adjustments686.73K0.23%
Region Currency:CNY
2023/FY
Stock NameRevenueRatio
East China region302.83M58.28%
Central China60.15M11.58%
Southwest area52.17M10.04%
Northwest region33.75M6.50%
Northeast area29.2M5.62%
North China23.79M4.58%
South China12.67M2.44%
其他业务收入/成本5.07M0.97%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Transferring Securities of Securities
Transferring Securities of Securities
Intraday-0.55%
Finance and Securities Lending
Finance and Securities Lending
Intraday-0.55%
High Throughput
High Throughput
Intraday-1.32%